This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories (ABT) slipped 1.25% to $125.12 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.79% to 6,774.76 and the Dow Jones Industrial Average  rising 0.14% to 47,951.85.
This was the stock's third consecutive day of losses.
Abbott Laboratories closed 11.41% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson &amp; Johnson (JNJ) fell 0.96% to $208.31, Pfizer Inc. (PFE) remained unchanged, and Merck &amp; Co. Inc. (MRK) rose 1.52% to $100.69.
Trading volume (5.9 M) remained 510,928 below its 50-day average volume of 6.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-18-25 1633ET

<p>Abbott Laboratories' stock fell 1.25% to $125.12 on Thursday, underperforming compared to competitors. This marks the third consecutive day of losses for the stock, which is 11.41% below its 52-week high. In contrast, Johnson & Johnson fell 0.96%, Pfizer remained unchanged, and Merck rose 1.52%.</p>

Abbott Laboratories Stock Underperforms Thursday When Compared To Competitors